|Day Low/High||165.43 / 166.37|
|52 Wk Low/High||114.27 / 197.00|
Jim Cramer's plan for getting through the heart of earnings season next week.
Is it a retest based on the damage the Fed has already done, the result of a breakdown in trade talks or a sign of a slowing global economy?
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.
Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.
So far 2019 is proving to be a year where things have a habit of working out right.
The company is set to report earnings on Jan. 29, so traders have a couple of weeks to watch the action.
This will be the craziest reporting season we've seen in ages, says Jim Cramer. He's got your game plan for next week.
A three-year decline in the shares of the maker of Botox will take more than a two-week bounce to reverse.
Plus: Jim Cramer interviews Apple CEO Tim Cook about innovation, investments and healthcare technology.
The RMPIA index was up for the year, while the S&P 500, DJIA, Russell 2000 and Nasdaq all finished 2018 in the red.
When I looked at the charts this morning I found a stock that could still decline further.
Buying stocks now means you are in the uncomfortable position of fighting the Fed as it tries to slow the economy.
These are currently situations where companies are facing serious lawsuits.
Allergan's textured breast implants have been linked to a rare form of cancer.
The CEOs who bring in the most money every year may not be who you expect. Who are the highest-paid CEOs?
At today's Analyst and Investor Conference hosted in New York, CEO Alex Wynaendts and Aegon's US management team will outline how targeted actions to simplify and grow the business are creating significant value for all stakeholders.
Still, there were some bullish aspects to the action today much as you might think otherwise.
We'll be out later with key thoughts from our discussion on what direction the portfolio should be taken as we quickly approach a new investment year.
Aegon today announces that its subsidiary in the United Kingdom has strengthened its existing partnership with Atos, signing a 15-year contract to service and administer its Existing Business (non-platform customers).
Aegon's Supervisory Board will propose to the Annual General Meeting of Shareholders in May 2019 to reappoint Alex Wynaendts (58) as Chief Executive Officer of the company, for a four-year term.
Let's check the charts and technical indicators for some guidance.
Jim Cramer's been saying that that if the Fed or the president blink in their wars against inflation and China you could have an up day. That's what we got.
Once the safest stocks in the book, the big-cap drug companies are now toxic.
The Dublin firm raised its outlook amid a delay in the launch of generic competition to its dry eye medication Restasis.
Global stocks attempted yet another rebound Tuesday, with reports of direction market intervention in China supporting prices in Asia and stronger-than-expected blue chip earnings putting European bourses on solid footing following a volatile session on Wall Street that saw a 900-point swing for the Dow Jones Industrial Average and a further worrying plunge in big-name tech companies.
My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.
Jim Cramer weighs in on Procter & Gamble, Six Flags, Western Digital, Allergan, Principal Financial Group.
Jim Cramer says somebody panicked, and their departure left behind a mess in the tech sector. But that spells a buying opportunity.
Aegon's subsidiary Transamerica today announces an agreement that would resolve litigation challenging certain monthly deduction rate adjustments on universal life insurance policies in the United States.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.